Taro Sato

发表

Abstract. Trifluridine (FTD)/tipiracil (TPI) plus bevacizumab (Bev) is a promising late‐line treatment in metastatic colorectal cancer (mCRC). Although chemotherapy‐induced neutropenia (CIN) is a well‐known predictor of FTD/TPI efficacy, whether CIN is a predictive marker of efficacy for FTD/TPI + B

K. Chìn, D. Takahari, H. Osumi, 2021 .

Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy

K. Chìn, D. Takahari, H. Osumi, 2020, Cancer medicine.

WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study).

K. Muro, Y. Hamamoto, K. Nagashima, 2022, Clinical colorectal cancer.

Development of a high-speed bioaerosol elimination system for treatment of indoor air

N. Negishi, Setsuko Koura, Tomoko Hori, 2022, Building and Environment.

Peripheral Blood Eosinophil Count Optimizes Pembrolizumab-Based Immunotherapy in The First-Line Setting of Advanced or Recurrent Non-Small Cell Lung Cancer

Y. Hosomi, Mao Uematsu, Taro Sato, 2021 .

Single-institute comparison of the efficacy of systemic chemotherapy for oesophagogastric junction adenocarcinoma and stomach adenocarscinoma in a metastatic setting

D. Takahari, H. Osumi, K. Yamaguchi, 2020, ESMO Open.

Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research

D. Takahari, H. Osumi, K. Yamaguchi, 2020, International Journal of Clinical Oncology.

Feasibility of Chemotherapy in Patients with Inflammatory Bowel Disease-Related Gastrointestinal Cancer.

Y. Doki, M. Mori, I. Takemasa, 2014, Hepato-gastroenterology.

Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report

Y. Fujii, A. Kakita, J. Murai, 2022, Journal of clinical medicine.

Clinical Impact of Primary Tumor Location and RAS, BRAF V600E, and PIK3CA Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer

D. Takahari, H. Osumi, K. Yamaguchi, 2021, Anticancer Research.

Effect of neutropenia on survival outcomes of patients with metastatic colorectal cancer receiving trifluridine/tipiracil plus bevacizumab

D. Takahari, H. Osumi, K. Yamaguchi, 2021, Oncology Letters.

Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy

E. Oki, M. Shiozawa, K. Ohtsubo, 2023, JCO precision oncology.